Australian-based Global Fund Management company
| i | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Nasdaq: REGN | Current | Pharmaceutical Preparations | $177M | 17.77% | $95.5B | Q3 2024 | Q3 2026 | 13F, Q3 2026 | ||
| Nasdaq: GOOGL | Current | Services-Computer Programming, Data Processing, Etc. | $101M | 10.16% | $3.25T | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |||
| Nasdaq: SHC | Current | Services-Misc Health & Allied Services, NEC | $97M | 9.70% | $4.6B | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |||
| NYSE: BRK.B | Current | Fire, Marine & Casualty Insurance | $76M | 7.64% | $1.21T | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |||
| Nasdaq: IBKR | Current | Security Brokers, Dealers & Flotation Companies | $75M | 7.54% | $129B | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |||
| Nasdaq: AMZN | Current | Retail-Catalog & Mail-Order Houses | $68M | 6.83% | $2.67T | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |||
| NYSE: PM | Current | Cigarettes | $58M | 5.84% | $287B | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |||
| NYSE: DIS | Current | Services-Miscellaneous Amusement & Recreation | $40M | 4.06% | $197B | Q1 2026 | Q3 2026 | 13F, Q3 2026 | |||
| NYSE: CTVA | Current | Agricultural Production-Crops | $36M | 3.62% | $51.8B | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |||
| NYSE: COF | Current | National Commercial Banks | $34M | 3.42% | $107B | Q2 2025 | Q3 2026 | 13F, Q3 2026 | |||
| Nasdaq: FCNCA | Current | State Commercial Banks | $30M | 2.98% | $23.8B | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |||
| BBB FOODS INC | NYSE: TBBB | Current | Retail-Grocery Stores | $29M | 2.86% | $8.1B | Q4 2025 | Q3 2026 | 13F, Q3 2026 | ||
| Vaneck Etf Trust | Current | Fund | $22M | 2.18% | Q3 2024 | Q3 2026 | 13F, Q3 2026 | ||||
| NYSE: IHG | Current | Hotels & Motels | $22M | 2.18% | $25.3B | Q3 2026 | Q3 2026 | 13F, Q3 2026 | |||
| Ishares TR | Current | Fund | $17M | 1.72% | Q3 2024 | Q3 2026 | 13F, Q3 2026 | ||||
| NYSE: BF.B | Current | Beverages | $16M | 1.65% | $14.1B | Q1 2026 | Q3 2026 | 13F, Q3 2026 | |||
| NYSE: GHC | Current | Services-Educational Services | $13M | 1.33% | $5.2B | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |||
| Nasdaq: NKTR | Current | Pharmaceutical Preparations | $12M | 1.23% | $1.1B | Q1 2026 | Q3 2026 | 13F, Q3 2026 | |||
| Global-E Online Ltd. | Nasdaq: GLBE | Current | Services-Prepackaged Software | $9M | 0.92% | $5.9B | Q1 2026 | Q3 2026 | 13F, Q3 2026 | ||
| Nasdaq: ALNY | Current | Pharmaceutical Preparations | $9M | 0.88% | $19.8B | Q3 2025 | Q3 2026 | 13F, Q3 2026 | |||
| NYSE: NEM | Current | Gold and Silver Ores | $8M | 0.81% | $104B | Q2 2025 | Q3 2026 | 13F, Q3 2026 | |||
| CHEMICAL & MINING CO OF CHILE INC | NYSE: SQM | Current | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | $8M | 0.76% | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |||
| NYSE: B | Current | Gold and Silver Ores | $6M | 0.60% | $54.3B | Q2 2025 | Q3 2026 | 13F, Q3 2026 | |||
| Nasdaq: AUR | Current | Services-Computer Integrated Systems Design | $5M | 0.52% | $7.8B | Q1 2026 | Q3 2026 | 13F, Q3 2026 | |||
| NYSE: HLF | Current | Wholesale-Drugs, Proprietaries & Druggists' Sundries | $4M | 0.40% | $1.6B | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |||
| Nasdaq: RVMD | Current | Biological Products, (No Diagnostic Substances) | $4M | 0.39% | $34.5B | Q2 2026 | Q3 2026 | 13F, Q3 2026 | |||
| Liveramp Hldgs Inc | Current | $3M | 0.34% | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |||||
| Nasdaq: MDLZ | Current | Food and Kindred Products | $3M | 0.31% | $83.9B | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |||
| NYSE: TYL | Current | Services-Prepackaged Software | $3M | 0.27% | $16.1B | Q2 2026 | Q3 2026 | 13F, Q3 2026 | |||
| Nasdaq: PCTY | Current | Services-Prepackaged Software | $3M | 0.26% | $9.0B | Q1 2026 | Q3 2026 | 13F, Q3 2026 | |||
| NYSE: TPB | Current | Tobacco Products | $2M | 0.24% | $950M | Q4 2025 | Q3 2026 | 13F, Q3 2026 | |||
| NYSE: BBWI | Current | Retail-Retail Stores, NEC | $2M | 0.23% | $3.8B | Q3 2024 | Q3 2026 | 13F, Q3 2026 | |||
| Current | $2M | 0.18% | Q4 2025 | Q3 2026 | 13F, Q3 2026 | ||||||
| Nasdaq: OLED | Current | Electronic Components & Accessories | $0.8M | 0.08% | $3.7B | Q4 2025 | Q3 2026 | 13F, Q3 2026 | |||
| Nasdaq: VRSK | Current | Services-Computer Processing & Data Preparation | $0.4M | 0.04% | $25.7B | Q1 2026 | Q3 2026 | 13F, Q3 2026 | |||
| TREACE MEDICAL CONCEPTS, INC. | Nasdaq: TMCI | Current | Surgical & Medical Instruments & Apparatus | $0.1M | 0.01% | $285M | Q2 2026 | Q3 2026 | 13F, Q3 2026 | ||
| AN2 Therapeutics, Inc. | Nasdaq: ANTX | Current | Pharmaceutical Preparations | $0.1M | 0.01% | $198M | Q2 2026 | Q3 2026 | 13F, Q3 2026 | ||
| Nasdaq: ENVX | Current | Miscellaneous Electrical Machinery, Equipment & Supplies | $0.1M | 0.01% | $274M | Q3 2025 | Q3 2026 | 13F, Q3 2026 | |||
| Nasdaq: FATE | Current | Biological Products, (No Diagnostic Substances) | $0.1M | 0.01% | $123M | Q4 2025 | Q3 2026 | 13F, Q3 2026 | |||
| Nasdaq: PEPG | Current | Pharmaceutical Preparations | $0.0M | 0.00% | $370M | Q2 2026 | Q3 2026 | 13F, Q3 2026 | |||
| Nasdaq: PACB | Current | Laboratory Analytical Instruments | $0.0M | 0.00% | $550M | Q2 2026 | Q3 2026 | 13F, Q3 2026 | |||
| Nasdaq: CCCC | Current | Biological Products, (No Diagnostic Substances) | $0.0M | 0.00% | $320M | Q4 2025 | Q3 2026 | 13F, Q3 2026 | |||
| Nasdaq: SEER | Current | Laboratory Analytical Instruments | $0.0M | 0.00% | $77M | Q2 2026 | Q3 2026 | 13F, Q3 2026 | |||
| Nasdaq: CMRC | Current | Services-Prepackaged Software | $0.0M | 0.00% | $270M | Q2 2026 | Q3 2026 | 13F, Q3 2026 | |||
| Nasdaq: ALXO | Current | Pharmaceutical Preparations | $0.0M | 0.00% | $132M | Q2 2026 | Q3 2026 | 13F, Q3 2026 | |||
| Acumen Pharmaceuticals, Inc. | Nasdaq: ABOS | Current | Biological Products, (No Diagnostic Substances) | $0.0M | 0.00% | $14M | Q2 2026 | Q3 2026 | 13F, Q3 2026 | ||
| Nasdaq: ALEC | Current | Biological Products, (No Diagnostic Substances) | $0.0M | 0.00% | $342M | Q4 2025 | Q3 2026 | 13F, Q3 2026 | |||
| Blend Labs, Inc. | NYSE: BLND | Current | Services-Computer Programming, Data Processing, Etc. | $0.0M | 0.00% | $211M | Q2 2026 | Q3 2026 | 13F, Q3 2026 | ||
| Nasdaq: CHRS | Current | Biological Products, (No Diagnostic Substances) | $0.0M | 0.00% | $60M | Q4 2025 | Q3 2026 | 13F, Q3 2026 | |||
| NovaBridge Biosciences | Nasdaq: NBP | Current | Pharmaceutical Preparations | $0.0M | 0.00% | Q2 2026 | Q3 2026 | 13F, Q3 2026 | |||
| Milestone Pharmaceuticals Inc. | Nasdaq: MIST | Current | Pharmaceutical Preparations | $0.0M | 0.00% | $50M | Q4 2025 | Q3 2026 | 13F, Q3 2026 | ||
| Discover Finl Svcs | Exited | -100.0% | -$60M | Q3 2024 | Q1 2025 | 13F, Q1 2025 | |||||
| Nasdaq: MTCH | Exited | Services-Computer Programming, Data Processing, Etc. | -100.0% | -$25M | $8.9B | Q3 2024 | Q1 2025 | 13F, Q1 2025 | |||
| Nasdaq: ABVX | Exited | Pharmaceutical Preparations | -100.0% | -$15M | $7.1B | Q3 2025 | Q3 2025 | 13F, Q3 2025 | |||
| VERTEX PHARMACEUTICALS INC / MA | Nasdaq: VRTX | Exited | Pharmaceutical Preparations | -100.0% | -$9M | $132B | Q3 2024 | Q3 2024 | 13F, Q3 2024 | ||
| NYSE: PINS | Exited | Services-Computer Programming, Data Processing, Etc. | -100.0% | -$8M | $9.7B | Q3 2024 | Q1 2026 | 13F, Q1 2026 | |||
| NYSE: SBH | Exited | Retail-Retail Stores, NEC | -100.0% | -$3M | $1.7B | Q1 2025 | Q1 2026 | 13F, Q1 2026 | |||
| NYSE: FICO | Exited | Services-Business Services, NEC | -100.0% | -$3M | $14.8B | Q4 2025 | Q4 2025 | 13F, Q4 2025 | |||
| James River Group Holdings, Inc. | Nasdaq: JRVR | Exited | Fire, Marine & Casualty Insurance | -100.0% | -$2M | $135M | Q4 2025 | Q1 2026 | 13F, Q1 2026 | ||
| Global Blue Group Holding AG | Exited | -100.0% | -$0.9M | Q1 2025 | Q2 2025 | 13F, Q2 2025 | |||||
| Caribou Biosciences, Inc. | Nasdaq: CRBU | Exited | Biological Products, (No Diagnostic Substances) | -100.0% | -$0.0M | Q4 2025 | Q1 2026 | 13F, Q1 2026 | |||
| Nasdaq: PLRX | Exited | Pharmaceutical Preparations | -100.0% | -$0.0M | $38M | Q4 2025 | Q1 2026 | 13F, Q1 2026 | |||
| Nasdaq: IVVD | Exited | Biological Products, (No Diagnostic Substances) | -100.0% | -$0.0M | $132M | Q4 2025 | Q1 2026 | 13F, Q1 2026 | |||
| Gossamer Bio Inc | Exited | -100.0% | -$0.0M | Q2 2026 | Q2 2026 | 13F, Q2 2026 | |||||
| Rani Therapeutics Holdings, Inc. | Nasdaq: RANI | Exited | Pharmaceutical Preparations | -100.0% | -$0.0M | $67M | Q4 2025 | Q1 2026 | 13F, Q1 2026 | ||
| Nasdaq: GUTS | Exited | Surgical & Medical Instruments & Apparatus | -100.0% | -$0.0M | $13M | Q4 2025 | Q1 2026 | 13F, Q1 2026 |